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We generated the PBMC1-iPS4F1 cell line using the reprogramming
factors Oct3/4, Sox2, Klf4 and c-Myc (Takahashi et al., 2007) (Yu
et al., 2007) included in the CytoTune®-iPS 2.0 Reprogramming Sys-
tem (Life Technologies, Invitrogen), which is based on a modiﬁed,
non-transmissible form of Sendai virus (SeV). PBMC1-iPS4F1 colonies
displayed a typical round shape morphology with small, tightly packed
cells with a high nucleus/cytoplasm ratio and prominent nucleoli
(Fig. 1A), and they were positive for alkaline phosphatase activity
(Fig. 1B). We conﬁrmed the absence of exogenous reprogramming
transgenes by RT-PCR after 8 passages and two heat treatments (6 days
at 39 °C) to eliminate temperature sensitive mutant SeV (Fig. 1C).
The PBMC1-iPS4F1 cell line has been adapted to feeder-free culture
conditions and displays a normal karyotype (46, XX) after extensive
mechanical and enzymatic transfers (Fig. 1D). The iPSC line was also
characterized using a genetic ﬁngerprinting assay by microsatellite
analysis.
The endogenous expression of the pluripotency associated
transcription factors Oct3/4, Sox2, Rex1 and Nanog was evaluated
by RT-PCR (Fig. 2A). We also conﬁrmed the protein expression levels
of the pluripotencymarkers Oct3/4, SSEA3, SSEA4, Tra1-60 and Tra1-81
by ﬂow cytometry analysis (Fig. 2B).
The in vivo differentiation capacity of the PBMC1-iPS4F1 cell line
was demonstrated by teratoma formation. The teratomas showed
expression of representative markers of the three germ layers (Glial
Fibrilar Acid Protein/GFAP for ectoderm, Vimentin for mesoderm, and
Cytokeratin/CK AE1-AE3 for endoderm) (Fig. 3A). In addition, in vitro
differentiation capacity was tested by spontaneous embryoid body
(EB) differentiation. The cells inside the EBs were able to differentiate
to the three germ layers, demonstrated by the expression of representa-
tive markers of each layer (β-III-tubulin for ectoderm, Vimentin for
mesoderm and CK AE1-AE3 for endoderm) (Fig. 3B). We also routinely
monitor the PBMC1-iPS4F1 cell line to conﬁrm the absence of Myco-
plasma contamination.
Materials and methods
Generation of vector free PBMC1-iPS4F1 cell line from PBMCs
A blood sample was obtained from a healthy 39-years old woman
with a Spanish genetic background accordingly with the Andalusian
Ethics Review Board for Cellular Reprogramming requirements and
with Spanish and EU legislation. The blood sample was diluted 1:2Fig. 1. Characterization of PBMC1-iPS4F1 cell line (A) PBMC1-iPS4F1 cell line displays a typical
enzymatic activity. (C) Exogenous reprogramming factors and SeV vector silencingwas conﬁrm
the normal karyotype displayed by PBMC1-iPS4F1 cell line.(vol:vol) in PBS and centrifuged with Ficoll Paque™ PLUS (GE
Healthcare) to separate and isolate peripheral blood mononuclear
cells (PBMCs). Isolated PMBCs were cultured for 4 days in PBMC medi-
um consisting in StemSpan™ SFEM (StemCell Technologies) supple-
mented with 100 ng/ml hSCF, 100 ng/ml hFLT3L, 20 ng/ml hTPO,
10 ng/ml G-CSF and 2 ng/ml hIL3 (Peprotech). The PBMCs were then
transferred to a 12-well ﬁbronectin coated plate (BD BioCoat™) and ex-
posed overnight to SeV particles (CytoTune®-iPS 2.0 Reprogramming
kit, Life Technologies, Invitrogen) at MOI:3 in the presence of 8 μg/ml
Polybrene (Sigma-Aldrich) and 10 μMY-27632 (Sigma-Aldrich). Subse-
quently, the SeV particles were removed by centrifugation and the
transduced cells were grown for 3 days in PBMC medium. Then, the
cells were transferred onto irradiated human mesenchymal stem cells
(hMSC, Inbiobank) (Montes et al., 2009) and cultivated one day with
PBMC medium. On the second day, the cells were cultivated in 1:1
(vol:vol) PBMC medium and pluripotent stem cell (PSC) medium
(KO-DMEM supplemented with 20% knockout serum replacement
(both from Life Technologies), 8 ng/ml bFGF2 (Milteny Biotec), 10 μM
Y-27632 (Sigma-Aldrich), 1 mM glutamine, 1% MEM non-essential
amino acids and 0.1 mM 2-mercaptoethanol (all from Life Technolo-
gies). From the third day onwards, the cells were cultured in PSCmedi-
um. Seven days after transduction, emerging iPSC colonies were picked
individually and expanded for characterization.
Phosphatase alkaline analysis
PBMC1-iPS4F1 cells were seeded on 12-well Matrigel™ coated plates.
After 5 days in culture, we tested the phosphatase alkaline enzymatic
activity using Alkaline phosphatase detection kit (Merck-Millipore)
following manufacturer's instructions (Fig. 1B).
Analysis of expression of exogenous reprogramming factors
Silencing of the exogenous reprogramming factors was analyzed by
RT-PCR following manufacturer's instructions (CytoTune®-iPS 2.0
Reprogramming kit, Life Technologies, Invitrogen). TotalmRNAwas iso-
lated using RNeasy Plus Mini Kit (Qiagen). 2 μg of total RNA were used
to synthesize cDNA by First-Strand cDNA Synthesis kit (GE Healthcare)
and the resulting cDNAwas diluted inwater at a concentration of 10 ng/
μl. 20 ng were used for PCR ampliﬁcation (Taq DNA Polymerase,
Qiagen). Initially, RT-PCR analysis revealed Klf4 SeV elimination and
maintenance of the temperature sensitive mutants c-Myc and KOS
(Klf4, Oct3/4, Sox2) SeVs (data not shown). After two heat treatmentsround shape colonymorphologywith small, tightly packed cells. (B) Alkaline phosphatase
ed by RT-PCR. H9 cell linewas used as negative control. (D) Typical GTG-banding showing
Fig. 2.Expression of pluripotency-associatedmarkers in PBMC1-iPS4F1. (A) Endogenouspluripotencymarkers Sox2, Rex1, Nanog andOct3/4were conﬁrmedbyRT-PCR. (B) Expression of
pluripotency-associatedmarkers SSEA3, SSEA4, TRA1-81, TRA 1-60 and OCT3/4 at protein level by FACS analysis. The inset shows the staining using the corresponding irrelevant isotype-
matched antibody.
616 R. Montes et al. / Stem Cell Research 15 (2015) 614–617(39 °C for 6 days), the PBMC1-iPS4F1 cell line at passage 8 (p8) showed
the complete removal of all thermo sensitive SeVs by RT-PCR (Fig. 1C).
Pluripotent stem cell markers expression
RT-PCR
cDNA from totalmRNAwas synthesized as previously described and
used for RT-PCR. Endogenous pluripotency-associated transcription
factors (Sox2, Rex1, Nanog and Oct3/4) and β-Actin genes were ampli-
ﬁed using the primers detailed in Table 1. cDNA from H9 cell line
(WA09-Wicell) was used in the reaction to validate pluripotency
markers expression in PBMC1-iPS4F1 cell line (Fig. 2A) (Ramos-Mejia
et al., 2012).
Flow cytometry analysis
To check pluripotency-associated markers expression at protein
level, FACS analyses were performed. PBMC1-iPS4F1 colonies were dis-
sociated by incubation with TrypLE Express (Life Technologies) for
5 min. Then, the cells were suspended in FACS buffer (5% FBS 2 mM
EDTA in PBS) at a concentration of 1–2 × 105 cells per 100 μl and incu-
batedwith the speciﬁc primary antibody for 30min at 4 °C.We analyzed
the pluripotency-associated surface markers SSEA3 (PE, BioScience),Fig. 3. Three germ layers differentiation testing of PBMC1-iPS4F1. (A) In vivo differentiation te
immunohistochemistry analysis of mesoderm (Vimentin), endoderm (CK AE1-AE3) and ec
21 days (see brightﬁeld picture, BF) and analyzed for mesodermal (Vimentin), endodermal (CSSEA4 (Alexa Fluor® 647, BD Pharmingen), Tra1-60 (PE, BioScience)
and Tra1-81 (Alexa Fluor® 647, BD Pharmingen) and the intracellular
marker Oct3/4 (BD BioScience). An irrelevant isotype-match antibody
was always used as a negative control. To analyze Oct3/4, sequential in-
cubations with ﬁxation and permeabilization solutions were necessary
(A and B Fix & Perm Solutions, Invitrogen). After Oct3/4 primary
antibody incubation, the cells were incubated with FITC-conjugated
secondary antibody (BD BioScience). Then, the cells were washed
with FACS buffer and stained with 7-aminoactinomycin D (7-AAD)
(BD Bioscience) for 5 min at RT. Stained cells were analyzed using
a FACS Canto and FACS Diva™ software program (BD Bioscience)
(Fig. 2B) (Ramos-Mejia et al., 2010).
Three germ layer differentiation capacity
In vivo differentiation of the iPSC line
We used an in vivo teratoma formation assay to test the capacity
of the PBMC1-iPS4F1 cell line to differentiate to the three germ
layers. Feeder-free iPSCs colonies were dissociated with collagenase IV
(Gibco) to obtain a single cell suspension. 2–5 × 106 cells per
mouse were injected subcutaneously into dorsal ﬂanks of SCID mice
(NOD/LtSz-scid interleukin-2Rγ−/− mice, The Jackson Laboratory).st by teratoma formation assay. The pictures show hematoxylin/eosin staining (H&E) and
toderm (GFAP). (B) In vitro differentiation study by EB formation. EBs were grown for
K AE1-AE3) and ectodermal (β-III Tubulin) markers expression.
Table 1
Primers sets used for pluripotency-associated genes expression by RT-PCR.
Gene Primer sequence Product size
Β-Actin Forward: CTGGAACGGTGAAGGTGACA
Reverse: AAGGGACTTCCTGTAACAATGCA
165 bp
Oct4 Forward: AGTGAGAGGCAACCTGGAGA
Reverse: ACACTCGGACCACATCCTTC
110 bp
Sox2 Forward: TCAGGAGTTGTCAAGGCAGAGAAG
Reverse: CTCAGTCCTAGTCTTAAAGAGGCAGC
80 bp
Rex1 Forward: CAGATCCTAAACAGCTCGCAGAAT
Reverse: GCGTACGCAAATTAAAGTCCAGA
306 bp
Nanog Forward: TGCAGTTCCAGCCAAATTCTC
Reverse: CCTAGTGGTCTGCTGTATTACATTAAGG
96 bp
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injection and mice were euthanized at ~15 weeks post-injection. Tera-
tomas were ﬁxed and embedded in parafﬁn. The sections were stained
with hematoxylin/eosin or by immunocytochemistry to detect the ex-
pression of GFAP (ectoderm), Vimentin (mesoderm) and CK AE1-EA3
(endoderm) as previously described (Gutierrez-Aranda et al., 2010)
(Fig. 3A). The Animal Care Ethics Committee of the University of
Granada approved all animal protocols.
In vitro differentiation of the iPSC line
The in vitro pluripotency capacity of the PBM1-iPS4F1 cell line
was tested by spontaneous EB differentiation. One to two days before
reaching conﬂuence, 1 ml of Matrigel 1:6 (diluted in KO-DMEM)was
added to the culture. The conﬂuent iPSC culture was washed with
PBS and incubated with collagenase IV (Gibco) for 1 min. Then, colonies
were rinsed, scrapped and cultured in ultra-low attachment wells
(Sigma-Aldrich) to induce EB formation. EBs were cultured for 21 days
with PSC medium without bFGF2 for spontaneous differentiation to the
three germ layers. Medium changes were performed every 2–3 days. At
the end of differentiation, EBs were centrifugated and the pellet was
ﬁxed and embedded in parafﬁn. Sectionswere immunostained to analyze
the germ layer associated markers: β-III-tubulin for ectoderm, Vimentin
for mesoderm and CK AE1-EA3 for endoderm (Fig. 3B).
Veriﬁcation and authentication
Demonstration of intact genome of the PBMC1-iPS4F1. Chromosomal
analysis was performed by GTG-banding analysis at the Andalusian
Public Health SystemBiobank, Spain, according to the International Sys-
tem Cytogenetics Nomenclature recommendations (Shaffer, 2012)
(Catalina et al., 2007). As shown in Fig. 1D, PBMC1-iPS4F1 cell line
displays a normal karyotype (46, XX).PBMC1-iPS4F1 cell line identity. HLA analysis was employed for cell
identiﬁcation. HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQB1 loci
were typed (A*03:02, *31:01; B*15:01, *51:01; C*03:03, *15:02;
DRB1*07:01, *15:01; DQB1*02:02, *06:02).
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